BioMed Research International / 2014 / Article / Tab 6

Research Article

Drug Repositioning Discovery for Early- and Late-Stage Non-Small-Cell Lung Cancer

Table 6

Summary of top pathways returned by KEGG using DAVID for early- and late-stage cancer.

Early-stage NSCLC
TermCount% value

Leukocyte transendothelial migration418.20.00294
Glycolysis/gluconeogenesis 313.60.00982
Epithelial cell signaling in Helicobacter pylori infection313.60.0125
Cell adhesion molecules (CAMs)313.60.0432
Tight junction313.60.0444
Focal adhesion313.60.0911

Late-stage NSCLC
TermCount% value

Cell cycle1219.7
Oocyte meiosis813.1
Progesterone-mediated oocyte maturation69.8
DNA replication34.90.0250
p53 signaling pathway34.90.0791